Mon panier

Klotho beta

Klotho beta Informations sur la molécule

Nom anglaisKlotho betaNombre de médicaments commercialisés0
Nombre de médicaments cliniques3Alias de la cibleKlotho Beta,Klotho Beta-Like Protein,B-Klotho,Klotho Beta Like,Beta-Klotho,EC 3.2.1,BKL,BetaKlotho,KLB
Phase de R&D la plus avancéePhase 2 Clinical
Nom anglaisKlotho beta
Alias de la cibleKlotho Beta,Klotho Beta-Like Protein,B-Klotho,Klotho Beta Like,Beta-Klotho,EC 3.2.1,BKL,BetaKlotho,KLB
Nombre de médicaments commercialisés0
Nombre de médicaments cliniques3
Phase de R&D la plus avancéePhase 2 Clinical

Klotho beta Liste de produits

  • Attribut

    Protein (7)

  • Bibliothèque de produits

    En ligne (7)

  • Espèces

    Mouse (2)Cynomolgus / Rhesus macaque (1)Rat (1)Human (2)Rhesus macaque (1)

  • Étiquette

    His Tag (7)

  • Marqueur

    Unconjugated (5)Biotin-labeled (2)

Klotho betaContexte de la molécule

KLB (Klotho Beta) is a Protein Coding gene. Among its related pathways are RET signaling and HIV Life Cycle. GO annotations related to this gene include hydrolase activity, hydrolyzing O-glycosyl compounds and fibroblast growth factor binding. An important paralog of this gene is KL. Klotho Beta is a regulator in multiple metabolic processes, while its role in cancer remains unclear. We found the expression of βKlotho was down-regulated in human hepatocellular carcinoma tissues compared with that in paired adjacent non-tumourous liver tissues. Hepatoma cells also showed decreased expression of βKlotho compared with normal hepatocyte cells. Reintroduction of βKlotho into hepatoma cells inhibited their proliferation.

Klotho betaAlias de la molécule

betaKlotho,beta-klotho,BKL,KLB,klotho beta like,klotho beta-like protein

Informations sur les médicaments cliniques

Nom anglaisCode de recherchePhase de R&DEntrepriseIndicationEssai clinique
NGM-313NGM-313; MK-3655Phase 2 ClinicalNGM Biopharmaceuticals IncHepatitis; Metabolic Dysfunction-Associated Steatotic Liver Disease; Obesity
Details
JMT-202JMT202; JMT-202Phase 2 ClinicalShanghai Jmt-Bio IncHypertriglyceridemia
Details
DR-10624DR-10624; DR10624Phase 2 ClinicalZhejiang Doer Biologics CorpDiabetes Mellitus; Diabetes Mellitus, Type 2; Hypertriglyceridemia; Metabolic Dysfunction-Associated Steatotic Liver Disease; Metabolic Syndrome; Obesity; Overweight
Details
  • Informations sur la molécule
  • Liste de produits
  • Informations sur les médicaments cliniques